CMKLR1 and hyperlipidemia: To exemplify the importance of this pathway, targeted deletion of ERV1/ChemR23 in mouse models of hyperlipidemia drove pro-atherogenic signaling, which was reversed upon activation of this pathway with either dietary EPA intervention or treatment with RvE1 (12).